Detail akcie Takeda Pharm online

Business Summary: Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research and development, manufacture, sale and licensing of pharmaceuticals. The Company focuses on the main business areas of gastrointestinal diseases, rare diseases, plasma derivatives (immune diseases), oncology (cancer), and neuroscience (neuropsychiatric diseases). The Company focuses on three research and development areas: innovative biopharmaceuticals with the focus on gastrointestinal and inflammatory diseases, neuroscience, and oncology, plus plasma derivatives and vaccines. Most of the pharmaceuticals treat rare diseases in the focus disease areas and the plasma derivatives area. The Company operates in Japan, the United States, Europe, and China.
Financial Summary: BRIEF: For the nine months ended 31 December 2024, Takeda Pharmaceutical Co Ltd revenues increased 10% to Y3.528T. Net income applicable to common stockholders increased 44% to Y211.08B. Revenues reflect United States segment increase of 9% to Y1.841T, Europe And Canada (Country) segment increase of 10% to Y795.6B. Net income benefited from Impairment of Intangibles decrease of 76% to Y28.46B (expense).